|
|
Article: New data from Dana-Farber Cancer Institute, Department of Medical Oncology illuminate research in breast cancer.(Clinical report)
- Article from:
- Cancer Weekly
- Article date:
- December 9, 2008
CopyrightCOPYRIGHT 2008 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Current study results from the report, 'Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases,' have been published. "The purpose of the current study was to characterize the outcomes of patients with metastatic triple-negative breast cancers, including the risk and clinical consequences of central nervous system (CNS) recurrence. Using pharmacy and pathology records, a study group of 116 patients who were treated for metastatic triple-negative breast cancer at Dana-Farber Cancer Institute between January 2000 and June 2006 was identified," scientists in the United ...
Related newspaper, magazine, and journal articles:
|